Loeys-Dietz syndrome, a condition that affects blood vessels, bones and facial features, can be traced back to how cells send messages and signals during development. In this syndrome, genetic mutations cause disruptions in the molecules along a key communication system called the TGF-β signalling pathway. 

This miscommunication leads to the wide range of symptoms observed in Loeys-Dietz syndrome, including artery weakness, joint issues and more. Read on to learn about how this pathway works, what goes wrong in Loeys-Dietz syndrome and why understanding these aspects of the condition is important for diagnosis, care and future treatments. 

Introduction

Loeys-Dietz syndrome (LDS) is a rare genetic condition that affects the body’s connective tissue. This type of tissue is responsible for providing structure and strength to the skin, joints, organs and blood vessels. People with LDS may experience symptoms such as:

• Physical differences in the head and face include:
  • Cleft palate
  • A small/receding chin 
  • Blue tinge to the whites of the eye
  • Downward slant to eyes
• Problems with bones, like:
  • Scoliosis
  • Osteoarthritis 
  • Long fingers and toes
• Differences in the skin include:
  • Thin, translucent skin
  • Easy bruising
  • Wide scarring
• Eye problems
• Higher risk of allergies
• Bowel problems 

Whilst these symptoms may be present in other connective tissue disorders, LDS has its own key signs that are important in its diagnosis, namely those affecting the blood vessels and heart. These include:

• Widening of the arteries
• Twisted or spiralled arteries 
• Wide-spaced eyes
• Split or broad uvula 

Scientists have discovered that genetic mutations that cause LDS change how the transforming growth factor beta (TGF-β) signalling operates.¹ 

What is a signalling pathway? 

Signalling pathways are the way that all of the cells in the body can communicate with one another. Essentially, it is a string of self-controlling chemical reactions that work together to manage cell functions. Signalling pathways exist in almost every process in the body; hence, mutations that affect specific parts (like changes in specific protein structures) of signalling cascades can completely throw off an entire system. When this happens, signalling cascades can become over- or underactive, leading to severe multisystem consequences. 

This is exactly what happens in LDS, where genetic mutations affect the TGF-β signalling pathway. 

What is the TGF-β pathway?

TGF-β is a protein found throughout the body and serves many different functions. These range from controlling how cells divide to cell death to making new blood vessels.² 

When the TGF-B protein is released, it binds to specific receptors and is able to activate a chain reaction of chemical signals. There are various messengers along the way that regulate this signal until it reaches the storage area of DNA within the cell, the cell’s nucleus. There, it turns certain genes on or off, telling the cell to make more or less of a specific protein. 

How does the TGF-β pathway change in LDS

The mutations associated with LDS are found in one or more of the following genes:

• SMAD2 or SMAD3 - Genes encoding messengers along the TGF-β pathway
• TGFB2 or TGFB3 - Genes encoding different subtypes of TGF-β proteins
• TGFBR1 or TGFBR2 - Genes encoding TGF-β receptors

The proteins that are coded for by these genes either are responsible for signalling or help to regulate signalling on the TGF-β signalling pathway. Usually, in the LDS, mutations make this pathway overactive.³ 

The consequences of an overactive TGF-β pathway

The clinical characteristics of the disorder present differently depending on the type and severity of the genetic mutation causing LDS. The disorder is broken down into subtypes from type 1 to type 5, depending on these differing presentations, where type 1 is the most severe and type 5 the least.¹ 

All along the LDS spectrum, the overactive TGF-β pathway results in symptoms caused by improper development.¹ The way in which the different mutations affect clinical manifestation will be described below. 

LDS type 1

In LDS type 1, mutations to TGFBR1 commonly manifest in: 

• Facial differences
• Severe cardiovascular problems all around the body 
• Young onset of the disease
• Flexibility of joints
• Clubfoot
• Higher risk of neurodevelopmental problems

LDS type 2

In LDS type 2, mutations to TGFBR2 commonly manifest in:

• Minimal to no facial differences
• Cardiovascular problems 
• Some neurodevelopmental issues
• Clubfoot
• Dental problems
• Flexibility of joints

LDS type 3

In LDS type 3, mutations to SMAD3 commonly manifest in: 

• Cardiovascular problems, specifically with heart valves
• Some facial differences 
• The presence of osteoarthritis
• Spondylolisthesis
• Hernias

LDS type 4

In LDS type 4, mutations to TGFB2 commonly manifest in:

• Cardiovascular problems 
• Some facial differences
• Clubfoot
• Joint flexibility
• Hernias
• Scoliosis 

LDS type 5

In LDS type 5, mutations to TGFB3 commonly manifest in:

• Cardiovascular problems
• Lower risk of other symptoms

Why this knowledge matters 

Understanding how the TGF-β signalling pathway works in LDS is essential for making sense of the disorder and guiding treatment. Knowing which genes are involved not only helps with an accurate diagnosis but also allows doctors to predict the type and severity of symptoms.

Importantly, this knowledge opens the door to targeted treatments that can improve the quality of life of those suffering from this condition. For patients and families, staying informed about the science behind LDS is empowering, as it helps guide better care, earlier intervention and greater confidence in managing the condition. 

Summary

Loeys-Dietz syndrome (LDS) is a rare genetic condition that affects connective tissue throughout the body, leading to a wide range of symptoms. These include distinctive facial features, joint flexibility, skeletal differences, and, most critically, abnormalities in the blood vessels (specifically in the arteries). Central to LDS is the disruption of the TGF-β signalling pathway. Genetic mutations in this pathway cause it to become overactive, which leads to improper development of tissues and organs. Depending on the gene affected, LDS presents as a spectrum, with different subtypes with their own combination of features and severity. Understanding the role of the TGF-β pathway in LDS is vital, not only in accurate diagnosis but also in the prediction of outcomes and future treatment options. This knowledge can empower both healthcare providers and families in the management of the condition with confidence and care. 

FAQs

What is the triad of loeys-dietz syndrome?

The triad (set of three well-defined symptoms that point to a specific disease) of Loeys-Dietz syndrome includes eyes that are further apart than usual, a split uvula/cleft palate and a weak and winding aorta (main artery of the heart).⁴

What is the difference between marfan syndrome and loeys-dietz syndrome?

Marfan syndrome can present in a very similar way to Loeys-Dietz syndrome physically. However, these two conditions have different genetic causes and distinct features, for example, the triad of Loeys-Dietz syndrome described above. 

Were you born with loeys-dietz syndrome?

In short, yes. Since Loeys-Dietz syndrome is caused by a genetic mutation of genetics, it is present from birth, as it is a part of the DNA.